Abstract

The increasing number and global distribution of pathogens resistant to antimicrobial drugs is potentially one of the greatest threats to global health, leading to health crises arising from infections that were once easy to treat. Infections resistant to antimicrobial treatment frequently result in longer hospital stays, higher medical costs, and increased mortality. Despite the long-standing recognition of antimicrobial resistance (AMR) across many settings, there is surprisingly poor information about its geographical distribution over time and trends in its population prevalence and incidence. This makes reliable assessments of the health burden attributable to AMR difficult, weakening the evidence base to drive forward research and policy agendas to combat AMR. The inclusion of mortality and morbidity data related to drug-resistant infections into the annual Global Burden of Disease Study should help fill this policy void.

Keywords

MedicineAntibiotic resistanceGlobal healthIntensive care medicineBurden of diseaseDisease burdenEnvironmental healthDiseasePopulationIncidence (geometry)AntimicrobialDrug resistancePublic healthAntibioticsPathology

Affiliated Institutions

Related Publications

Publication Info

Year
2018
Type
letter
Volume
16
Issue
1
Pages
78-78
Citations
213
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

213
OpenAlex

Cite This

Simon I Hay, Puja C Rao, Christiane Dolecek et al. (2018). Measuring and mapping the global burden of antimicrobial resistance. BMC Medicine , 16 (1) , 78-78. https://doi.org/10.1186/s12916-018-1073-z

Identifiers

DOI
10.1186/s12916-018-1073-z